DK1129720T3 - Stabiliseret granulocyt-kolonistimulerende faktor - Google Patents

Stabiliseret granulocyt-kolonistimulerende faktor

Info

Publication number
DK1129720T3
DK1129720T3 DK01301576T DK01301576T DK1129720T3 DK 1129720 T3 DK1129720 T3 DK 1129720T3 DK 01301576 T DK01301576 T DK 01301576T DK 01301576 T DK01301576 T DK 01301576T DK 1129720 T3 DK1129720 T3 DK 1129720T3
Authority
DK
Denmark
Prior art keywords
stimulating factor
colony stimulating
granulocyte colony
stabilized
salt
Prior art date
Application number
DK01301576T
Other languages
Danish (da)
English (en)
Inventor
Josephine Nanette Hay
Kathleen Brimelow Williams
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1129720T3 publication Critical patent/DK1129720T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
DK01301576T 2000-02-29 2001-02-21 Stabiliseret granulocyt-kolonistimulerende faktor DK1129720T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18576900P 2000-02-29 2000-02-29

Publications (1)

Publication Number Publication Date
DK1129720T3 true DK1129720T3 (da) 2004-09-27

Family

ID=22682387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01301576T DK1129720T3 (da) 2000-02-29 2001-02-21 Stabiliseret granulocyt-kolonistimulerende faktor

Country Status (11)

Country Link
US (1) US6497869B2 (pt)
EP (1) EP1129720B1 (pt)
JP (1) JP3544180B2 (pt)
AT (1) ATE269716T1 (pt)
BR (1) BR0100827A (pt)
CA (1) CA2337661A1 (pt)
DE (1) DE60103940T2 (pt)
DK (1) DK1129720T3 (pt)
ES (1) ES2220673T3 (pt)
PT (1) PT1129720E (pt)
TR (1) TR200401573T4 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
DE60237841D1 (de) * 2001-11-13 2010-11-11 Genentech Inc Zusammensetzungen basierend auf APO2-Ligand/ TRAIL und ihre Verwendung
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
EP1682184B1 (en) 2003-11-04 2013-10-16 LEK Pharmaceuticals d.d. Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
CA2611200A1 (en) * 2005-06-06 2006-12-14 Novo Nordisk A/S Stabilised il-21 compositions
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
MX2010002348A (es) 2007-08-27 2010-07-30 Biogenerix Ag Formulacion liquida de g-csf.
DE202007018629U1 (de) 2007-08-27 2008-12-24 Biogenerix Ag Flüssigformulierung von G-CSF
JP5680534B2 (ja) 2008-07-23 2015-03-04 イーライ リリー アンド カンパニー 修飾されているウシｇ−ｃｓｆポリペプチドおよびそれらの使用
JP5769379B2 (ja) * 2010-03-17 2015-08-26 グンゼ株式会社 Ｄａｎｃｅタンパク質溶液
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
ITMI20120338A1 (it) * 2012-03-06 2013-09-07 Dr Andrea Bignotti Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
CA2998579A1 (en) * 2015-10-19 2017-04-27 Sandoz Ag Method for producing a recombinant protein with reduced impurities

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
GB2193621A (en) 1986-07-29 1988-02-17 Jan Mazura Plant support line
KR0133561B1 (ko) 1988-05-13 1998-04-21 스티븐 엠. 오드레 과립구 군체 자극인자의 정제방법
US5104651A (en) 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
JPH04502164A (ja) 1989-10-10 1992-04-16 アムジエン・インコーポレーテツド 犬科・猫科動物における感染の治療または予防のための化学組成物及び方法
GB9107846D0 (en) 1990-04-30 1991-05-29 Ici Plc Polypeptides
IE912365A1 (en) 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
DE4126983A1 (de) 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
FR2686900B1 (fr) 1992-01-31 1995-07-21 Rhone Poulenc Rorer Sa Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant.
FR2693907B1 (fr) 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
DE4242863A1 (de) 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
DE4242919A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
WO1995003034A1 (en) 1993-07-19 1995-02-02 Amgen Inc. Stabilization of aerosolized proteins
US5874075A (en) 1993-10-06 1999-02-23 Amgen Inc. Stable protein: phospholipid compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
DK0988861T3 (da) * 1998-08-17 2004-04-19 Pfizer Prod Inc Stabiliserede proteinpræparater

Also Published As

Publication number Publication date
ES2220673T3 (es) 2004-12-16
DE60103940D1 (de) 2004-07-29
PT1129720E (pt) 2004-08-31
BR0100827A (pt) 2001-11-27
JP2001278898A (ja) 2001-10-10
CA2337661A1 (en) 2001-08-29
TR200401573T4 (tr) 2004-08-23
ATE269716T1 (de) 2004-07-15
EP1129720A2 (en) 2001-09-05
JP3544180B2 (ja) 2004-07-21
US20020002133A1 (en) 2002-01-03
EP1129720A3 (en) 2001-09-26
US6497869B2 (en) 2002-12-24
EP1129720B1 (en) 2004-06-23
DE60103940T2 (de) 2005-07-28

Similar Documents

Publication Publication Date Title
DE60103940D1 (de) Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
YU72002A (sh) Benzoilpirazoli i njihova primena u ulozi herbicida
DE60219383D1 (de) Wässrige Beschichtungszusammensetzung
CA2336845A1 (en) Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
MX355976B (es) Composiciones antitranspirantes de eficacia mejorada que contienen estroncio.
DE60113822D1 (de) Haarwachstumsfördernde zusammensetzungen
EP1236398A4 (en) MICROBICIDAL COMPOSITIONS
UA97346C2 (ru) Стабильная эмульсионная композиция
DE60135451D1 (de) Gebrauch von polyphosphat zum verhindern von zahnerosion in sauren zusammensetzungen
WO2002017921A3 (en) Paroxetine compositions and processes for making the same
GB0015027D0 (en) Aqueous coating composition
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
HRP20030433B1 (en) Dermatological formulations containing clindamycin and a zinc-salt
DE60001302D1 (de) Wässrige Beschichtungszusammensetzung
DE60234592D1 (de) Wässrige zusammensetzung
ATE536886T1 (de) Stabilisierte feste zusammensetzungen von modifizierter faktor vii
CY1108791T1 (el) Φυτοενδυναμωτικο μεσον
DE60113659D1 (de) Orale zusammensetzung enthaltend 2'-hydroxypropiophenon
DE59907735D1 (de) Wachstumsregulierende wässrige zusammensetzungen
CA2406492A1 (en) All natural mineral treatment
GB0020965D0 (en) Improvements in or relating to aqueous compositions
ATE506989T1 (de) Harnstoffhaltige haarglättungszusammensetzung
DE60124839D1 (de) Wässrige Beschichtungszusammensetzung
CA2185549A1 (en) Stable strongly acidic aqueous compositions containing persulfate salts
ATE378471T1 (de) Wässrige zusammensetzung aus polyamidoaminen und tensiden zur papierherstellung